Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 12/20 | 0.49 |
| ▸ | MME | P08473 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 1/20 | 0.37 |
| ▸ | CPA1 | P15085 | 1/20 | 0.37 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.37 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.36 |
| ▸ | ITGA4 | P13612 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7975856 | 0.88 | ECE1 (0.52) | ECE1MMEMEN1KMT2AL3MBTL1 | |
| SCHEMBL7962316 | 0.88 | ECE1 (0.48) | ECE1MMEMEN1KMT2AITGB1 | |
| SCHEMBL7962528 | 0.76 | ECE1 (0.54) | ECE1MMEACECPA1ACE2 | |
| SCHEMBL7962587 | 0.76 | ECE1 (0.54) | ECE1MMEACECPA1ACE2 | |
| SCHEMBL7973787 | 0.75 | ECE1 (0.63) | ECE1MMEMEN1KMT2A | |
| SCHEMBL7973783 | 0.75 | ECE1 (0.63) | ECE1MMEMEN1KMT2A | |
| SCHEMBL7975859 | 0.74 | ECE1 (0.49) | ECE1MMEMEN1KMT2A | |
| SCHEMBL7975857 | 0.73 | ECE1 (0.57) | ECE1MMEMEN1KMT2AACE | |
| SCHEMBL7962318 | 0.73 | ECE1 (0.56) | ECE1MMEMEN1KMT2A | |
| SCHEMBL7973922 | 0.73 | ECE1 (0.67) | ECE1MMEMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001077095-A2 | DERIVATIVES OF ALPHA-MERCAPTOACETAMIDE | NOVARTIS AG (CH) | 2001-10-18 | — | — | WO | claimed |
| WO-2001077095-A2 | DERIVATIVES OF ALPHA-MERCAPTOACETAMIDE | NOVARTIS AG (CH) | 2001-10-18 | — | — | WO | disclosed |